Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-20-006233
Filing Date
2020-03-13
Accepted
2020-03-13 12:19:30
Documents
5
Period of Report
2020-03-13

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea119588-6k_tizianalife.htm 6-K 21679
2 FORM OF UNDERWRITING AGREEMENT ea119588ex1-1_tizianalife.htm EX-1.1 295175
3 OPINION OF ORRICK, HERRINGTON & SUTCLIFFE (UK) LLP ea119588ex5-1_tizianalife.htm EX-5.1 172894
4 PRESS RELEASE, DATED MARCH 11, 2020 ea119588ex99-1_tizianalife.htm EX-99.1 25234
5 GRAPHIC ex5-1_001.jpg GRAPHIC 5920
  Complete submission text file 0001213900-20-006233.txt   524310
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 20711554
SIC: 2834 Pharmaceutical Preparations